stoxline Quote Chart Rank Option Currency Glossary
  
Abbott Laboratories (ABT)
103.45  -0.93 (-0.89%)    06-13 16:00
Open: 103.635
High: 103.7
Volume: 3,505,890
  
Pre. Close: 104.38
Low: 102.61
Market Cap: 179,965(M)
Technical analysis
2024-06-13 4:41:19 PM
Short term     
Mid term     
Targets 6-month :  123.56 1-year :  127.28
Resists First :  105.79 Second :  108.98
Pivot price 103.81
Supports First :  100.63 Second :  83.73
MAs MA(5) :  105.74 MA(20) :  103.86
MA(100) :  110.46 MA(250) :  106.44
MACD MACD :  -0.3 Signal :  -0.7
%K %D K(14,3) :  46.8 D(3) :  62.9
RSI RSI(14): 44.6
52-week High :  121.63 Low :  89.66
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ABT ] has closed above bottom band by 45.1%. Bollinger Bands are 10.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 103.86 - 104.58 104.58 - 105.14
Low: 100.67 - 101.67 101.67 - 102.44
Close: 102.07 - 103.42 103.42 - 104.46
Company Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Headline News

Thu, 13 Jun 2024
Baird Financial Group Inc. Buys 297,789 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Thu, 13 Jun 2024
Abbott Laboratories (NYSE:ABT) Stake Lifted by Bayesian Capital Management LP - Defense World

Wed, 12 Jun 2024
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch

Tue, 11 Jun 2024
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch

Tue, 11 Jun 2024
Is Abbott Laboratories (NYSE:ABT) the Best Healthcare Dividend Stock? - Insider Monkey

Mon, 10 Jun 2024
Abbott Laboratories's Options: A Look at What the Big Money is Thinking - Abbott Laboratories (NYSE:ABT) - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 1,740 (M)
Shares Float 1,730 (M)
Held by Insiders 0.5 (%)
Held by Institutions 77 (%)
Shares Short 14,770 (K)
Shares Short P.Month 12,940 (K)
Stock Financials
EPS 3.21
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 22.3
Profit Margin 13.9 %
Operating Margin 15.3 %
Return on Assets (ttm) 6 %
Return on Equity (ttm) 14.7 %
Qtrly Rev. Growth 2.2 %
Gross Profit (p.s.) 0
Sales Per Share 23.17
EBITDA (p.s.) 5.95
Qtrly Earnings Growth -6.7 %
Operating Cash Flow 7,140 (M)
Levered Free Cash Flow 4,610 (M)
Stock Valuations
PE Ratio 32.22
PEG Ratio 2.7
Price to Book value 4.63
Price to Sales 4.46
Price to Cash Flow 25.21
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android